低FODMAP饮食对前列腺癌放疗期间直肠气体及直肠体积的影响:前瞻性预试验
该前瞻性预试验将25例接受放疗的前列腺癌患者设为干预组,要求其在放疗期间遵循低FODMAP饮食,并与25例未接受饮食建议的回顾性对照组比较。结果显示干预组直肠气体评分显著更低(p<.001),直肠体积更小(64.28 cm3 vs 71.40 cm3,p=.02),患者依从性良好。作者认为低FODMAP饮食可减少直肠气体和体积且可行,但需更大样本的前瞻性试验验证。
要点
- 低FODMAP饮食可显著降低前列腺癌放疗患者的直肠气体评分(p<.001)。
- 干预组直肠体积小于对照组(64.28 cm3 vs 71.40 cm3,p=.02)。
- 患者对该饮食干预的依从性和满意度良好,干预可行。
核心结论
- 低FODMAP饮食显著减少了前列腺癌放疗患者的直肠气体和直肠体积,且患者依从性极好。
- 仍需更大样本的前瞻性试验,并标准化评估胃肠道毒性和生活质量。
研究设计与样本
- 前瞻性干预组(n=25)在放疗期间遵循低FODMAP饮食,与未接受饮食建议的回顾性对照组(n=25)比较。
- 在计划CT和所有可获得的锥形束CT上,用半定量评分(1至5分)对直肠气体分类并测量直肠体积。
- 通过自评问卷评估患者依从性。
主要发现
- 共分析对照组266次(每例10.6次)和干预组280次(每例11.2次)CT扫描。
- 两组气体评分频率分布差异显著(p<.001),干预组评分更低。
- 干预组直肠体积为64.28 cm3(95%CI 60.92-67.65 cm3,SD 28.64 cm3),小于对照组的71.40 cm3(95%CI 66.47-76.32 cm3,SD 40.80 cm3)(p=.02)。
- 患者内标准差均值作为直肠体积变异性指标,干预组为22 cm3,对照组为23 cm3(p=.81)。
- 患者依从性和满意度令人满意。
关键数值与推荐
- 直肠气体采用半定量评分(1至5分)分类。
- 干预组直肠体积64.28 cm3(95%CI 60.92-67.65 cm3,SD 28.64 cm3),对照组71.40 cm3(95%CI 66.47-76.32 cm3,SD 40.80 cm3),p=.02。
- 气体评分频率分布比较p<.001。
- 患者内标准差均值干预组22 cm3,对照组23 cm3,p=.81。
临床怎么用
- 前列腺癌放疗期间可考虑采用低FODMAP饮食以减少直肠气体和直肠体积,患者依从性良好。
- 该干预可行性已在本预试验中显示,但需更大样本前瞻性试验验证对胃肠道毒性和生活质量的影响。
局限性
- 对照组为回顾性设计,未接受饮食建议。
- 样本量较小(每组25例)。
- 未标准化评估胃肠道毒性和生活质量。
- 试验为回顾性注册(DRKS00012955,2017年8月29日)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Small inter- and intrafractional prostate motion was shown to be a prerequisite for precise radiotherapy (RT) of prostate cancer (PCa) to achieve good local control and low rectal toxicity. As rectal gas and rectal volume are known to have a relevant effect on prostate motion, this study aims to reduce these parameters by using a Low FODMAP Diet (LFD) and to show feasibility of this intervention. METHODS: We compared a prospective intervention group (IG, n = 25) which underwent RT for PCa and whose patients were asked to follow a LFD during RT with a retrospective control group (CG, n = 25) which did not get any dietary advice. In the planning CT scan and all available cone beam CT scans rectal gas was classified based on a semiquantitative score (scale from 1 to 5) and rectal volume was measured. Furthermore, patients' compliance was evaluated by a self-assessment questionnaire. RESULTS: Clinical and treatment characteristics were well balanced between both groups. A total of 266 (CG, 10.6 per patient) and 280 CT scans (IG, 11.2 per patient), respectively, were analysed. The frequency distribution of gas scores differed significantly from each other (p < .001) with the IG having lower scores. Rectal volume was smaller in the IG (64.28 cm3, 95% CI 60.92-67.65 cm3, SD 28.64 cm3) than in the CG (71.40 cm3, 95% CI 66.47-76.32 cm3, SD 40.80 cm3) (p = .02). Mean intrapatient standard deviation as a measure for the variability of rectal volume was 22 cm3 in the IG and 23 cm3 in the CG (p = .81). Patients' compliance and contentment were satisfying. CONCLUSIONS: The use of a LFD significantly decreased rectal gas and rectal volume. LFD was feasible with an excellent patients' compliance. However, prospective trials with a larger number of patients and a standardized evaluation of gastrointestinal toxicity and quality of life are reasonable. TRIAL REGISTRATION: German Clinical Trials Register, DRKS00012955. Registered 29 August 2017 - Retrospectively registered, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00012955.
引用
- Schaefer C, Zamboglou C, Volegova-Neher N, et al. Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer - a prospective pilot study. Radiat Oncol. 2020. PMID: 32000818. doi:10.1186/s13014-020-1474-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。